Mark Unruh, médico


Mark L. Unruh, MD, MS, is a Professor and Chair of the Internal Medicine Department at the University of New Mexico (UNM). He is also the Associate Director of UNM Clinical & Translational Science Center. Dr. Unruh also serves on the steering committee of the SONG Initiative to develop a uniform fatigue measure for CKD and leads the UNM site and patient-reported outcomes for a trial examining the impact of Trazadone versus cognitive behavioral therapy for insomnia.

Dr. Unruh received his medical degree from the University of Chicago Pritzker School of Medicine. He is a leading physician-scientist performing research that's focused on interventions to improve patient-centered outcomes in CKD. Dr. Unruh’s primary research focus has been to improve the measurement and dissemination of patient-reported outcomes in the CKD population. He currently serves as the PRO leader 4 NIDDK/PCORI funded trials.

Additionally, Dr. Unruh’s investigation of subjective and objective sleep quality and sleep disorders in patients with CKD aims to find targeted interventions to improve sleep and daytime functioning. To better understand the sleep quality in the CKD population, Dr. Unruh has worked with community cohorts to describe sleep quality and sleep apnea in the general population. He has recently completed trials assessing the role of volume overload in the risk of obstructive sleep apnea.

Áreas de especialidad



Título de medicina:

University of Chicago Pritzker School of Medicine


Sistema de Salud de la Universidad de Pennsylvania


Nephrology - University of Pennsylvania Health System

Publicaciones clave